Implementation of a Market Entry Reward within the United States.

Journal Article (Journal Article)

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to "value-based" payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.

Full Text

Published version (via Digital Object Identifier)

Duke Authors

McClellan, Mark B

Cited Authors

Daniel, GW; Schneider, M; Lopez, MH; McClellan, MB

Published Date

June 2018

Published In

The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics

Volume / Issue

46 / 1_suppl

Start / End Page

50 - 58

PubMed ID

30146957

Electronic International Standard Serial Number (EISSN)

1748-720X

International Standard Serial Number (ISSN)

1073-1105

Digital Object Identifier (DOI)

10.1177/1073110518782915

Scholars@Duke